RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Isoliensinine inhibits mitophagy and sensitizes T cell malignancies for STING-mediated NK clearance.
Isoliensinine inhibits mitophagy and sensitizes T cell malignancies for STING-mediated NK clearance.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
线粒体 DNA(mtDNA)损伤和积累可激活 cGAS-STING DNA 感知通路,促进免疫细胞清除肿瘤细胞。维持细胞质 mtDNA 水平对持续免疫活化至关重要。T 细胞恶性肿瘤(T-CM)泛指不同阶段 T 淋巴细胞异常克隆增殖所致的疾病。T-CM 免疫治疗面临挑战,原因是缺乏能够区分恶性与正常 T 细胞的特异性抗原。由于内源性 STING 活化可促进免疫细胞清除 T-CM,研究者探讨从莲子胚芽提取的天然化合物异莲心碱(IsoL)能否通过肿瘤细胞 mtDNA 介导的免疫应答增强 NK 细胞清除作用。为评估 IsoL 是否调节对 T-CM 的免疫识别和清除,研究者先用 IsoL 处理 3 种 T-CM 细胞系(Jurkat、Molt4、Hut102),再与 NK-92MI 细胞共培养。
结果显示,IsoL 通过诱导 ROS 依赖性线粒体损伤,并经抗氧化酶过氧化物还原酶 1(PRDX1)抑制线粒体自噬,促进细胞质 mtDNA 积累。T-CM 中缺失 PRDX1 也会诱导 ROS 依赖性线粒体 DNA 损伤,并阻断线粒体自噬;其机制是阻止成熟 PINK1 积累,而 PINK1 对通过招募 Parkin 至受损线粒体启动线粒体自噬至关重要。
值得注意的是,IsoL 可在体外诱导活化配体表达、增强 NK 细胞浸润,并增加 T-CM 凋亡。此外,研究证实 IsoL 可使 T-CM 在体内外更易被 NK 细胞清除。这些结果提示 IsoL 可能成为增强 T-CM 免疫治疗的潜在药物。
Mitochondrial DNA (mtDNA) damage and accumulation activate the cGAS-STING DNA-sensing pathway, which promotes immune clearance of tumor cells. Maintenance of the cytosolic level of mtDNA is key to sustain immune activation. T cell malignancies (T-CMs) are a general name of diseases with abnormal clonal proliferation of T lymphocytes at various stages. Immunotherapy of T-CMs is challenged by the lack of specific antigens to discriminate T-CMs from normal T cells.
As intrinsic STING activation can promote the clearance of T-CMs by immune cells, we herein explored whether isoliensinine (IsoL), a natural compound from Nelumbinis Plumula could enhance NK clearance by mtDNA-mediated immune responses in tumor cells. To investigate whether IsoL modulated immune recognition and clearance of T-CMs, we pre-treated three T-CM cell lines (Jurkat, Molt4 and Hut102) with IsoL then co-cultured with NK-92MI cells.
We showed that IsoL pre-treatment promoted cytosolic mtDNA accumulation by inducing ROS-dependent mitochondrial damage and inhibiting mitophagy via peroxiredoxin 1 (PRDX1), an antioxidant enzyme.
Loss of PRDX1 in T-CMs also induced ROS-dependent mitochondrial DNA damage, and blocked mitophagy by preventing accumulation of mature PINK1, which was required to initiate mitophagy via recruiting Parkin to the damaged mitochondria. Remarkably, IsoL could induce expression of activating ligands in vitro, enhance NK cell infiltrations, and increase apoptosis of T-CMs.
Moreover, we demonstrated that IsoL could sensitize T-CMs for NK clearance in vitro and in vivo. These results suggest that IsoL could be a potential therapeutic agent to enhance immune therapy of T-CMs.
MEMBER ACCOUNT
登录成功会直接打开下一页。